ST. LUKES HOSPITAL OF DULUTH
1. Target Overview & Investment Thesis
ST. LUKES HOSPITAL OF DULUTH is a 238-bed suburban community hospital in ST. LOUIS, MN with $494.0M in net patient revenue and a -9.3% operating margin. The hospital serves a payer mix of 37.2% Medicare, 23.0% Medicaid, and 39.8% commercial.
Thesis: Undervalued. Our ML models identify $36.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -9.3% to -2.0% (+736bps).
| Net Revenue HCRIS | $494.0M |
| Current EBITDA COMPUTED | $-46.1M |
| Operating Margin COMPUTED | -9.3% |
| Occupancy HCRIS | 58.5% |
| Revenue / Bed COMPUTED | $2.1M |
| Net-to-Gross HCRIS | 39.0% |
| Distress Probability ML | 51.5% |
2. Market Context & Competitive Position
MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -9.3% places it below the state median. Among 14 size-comparable peers (119-476 beds), the median margin is -3.4%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (119-476), prioritizing same-state peers. 14 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ST. LUKES HOSPITAL OF DULUTH (Target) | MN | 238 | $494.0M | -9.3% |
| HENNEPIN COUNTY MEDICAL CENTER | MN | 335 | $1.19B | -11.2% |
| CHILDRENS HEALTH CARE | MN | 400 | $965.5M | -3.1% |
| ST. CLOUD HOSPITAL | MN | 458 | $943.6M | -1.7% |
| REGIONS HOSPITAL | MN | 423 | $862.7M | -7.6% |
| MERCY HOSPITAL | MN | 464 | $783.1M | -7.3% |
| UNITED HOSPITAL | MN | 362 | $762.9M | -10.0% |
| PARK NICOLLET METHODIST HOSPIT | MN | 353 | $741.7M | 3.1% |
| NORTH MEMORIAL HEALTH HOSPITAL | MN | 328 | $571.4M | -37.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $36.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $10.4M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $9.9M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $9.8M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $6.0M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $316K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-46.1M |
| + RCM Uplift | +$36.4M |
| Pro Forma EBITDA | $-9.7M |
| Current Margin | -9.3% |
| Pro Forma Margin | -2.0% |
| WC Released (1x) | $18.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-70.9M | $59.5M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-70.9M | $42.5M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-63.8M | $139.4M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-63.8M | $133.2M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-78.0M | $-99.2M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-78.0M | $-134.5M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (23.0%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 51.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 14 hospitals with 119-476 beds
- Same-state prioritization (n=15)
- Comp margins: P25=-7.7% / P50=-3.4% / P75=-0.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.